BamSEC and AlphaSense Join Forces
Learn More

Cubist Pharmaceuticals Inc

Formerly NASDAQ: CBSTZ

Material Contracts Filter

EX-10.1
from 8-K 16 pages Cubist Pharmaceuticals, Inc. 2014 Severance Plan and Summary Plan Description Effective December 8, 2014
12/34/56
EX-10.1
from 10-Q 10 pages Confidential Treatment Amendment No. 7 to the Manufacturing and Supply Agreement Entered Into as of September 30, 2001 by and Between Acs Dobfar, Spa and Cubist Pharmaceuticals, Inc
12/34/56
EX-10.6
from 10-Q 6 pages Cubist Pharmaceuticals, Inc. 2014 Omnibus Incentive Plan Restricted Stock Unit Agreement for NON-U.S. Participants
12/34/56
EX-10.5
from 10-Q 4 pages Cubist Pharmaceuticals, Inc. 2014 Omnibus Incentive Plan Restricted Stock Unit Agreement for U.S. Participants
12/34/56
EX-10.4
from 10-Q 4 pages Cubist Pharmaceuticals, Inc. 2014 Omnibus Incentive Plan Restricted Stock Unit Agreement for Directors
12/34/56
EX-10.3
from 10-Q 7 pages Cubist Pharmaceuticals, Inc. 2014 Omnibus Incentive Plan Stock Option Agreement for NON-U.S. Participants
12/34/56
EX-10.2
from 10-Q 5 pages Cubist Pharmaceuticals, Inc. 2014 Omnibus Incentive Plan Stock Option Agreement for U.S. Participants
12/34/56
EX-10.1
from 10-Q 4 pages Cubist Pharmaceuticals, Inc. 2014 Omnibus Incentive Plan Stock Option Agreement for Directors
12/34/56
EX-10.38
from 10-K 3 pages Amendment # 3 to the License Agreement
12/34/56
EX-10.13
from 10-K 7 pages Short-Term Incentive Plan (Sti Plan) Amended and Restated as of January 1, 2014
12/34/56
EX-10.3
from 10-Q 2 pages Cubist Pharmaceuticals, Inc. Amended and Restated Director Compensation and Benefits Program (Adopted on September 24, 2013*) Director Compensation
12/34/56
EX-10.1
from 10-Q 3 pages Amendment No. 6 to the Manufacturing and Supply Agreement Entered Into as of September 30, 2001 by and Between Acs Dobfar, Spa and Cubist Pharmaceuticals, Inc
12/34/56
EX-10.1
from 8-K 59 pages Contingent Value Rights Agreement by and Between Cubist Pharmaceuticals, Inc. and American Stock Transfer & Trust Company, LLC Dated as of October 24, 2013
12/34/56
EX-10.3
from S-4/A 41 pages Series a Convertible Preferred Stock Purchase Agreement by and Between Optimer Pharmaceuticals, Inc. and Cubist Pharmaceuticals, Inc. Dated as of September 16, 2013
12/34/56
EX-10.1
from 8-K 18 pages Contingent Value Rights Agreement
12/34/56
EX-10.12
from 425 25 pages Disclosure of Agency Relationship
12/34/56
EX-10.12
from 8-K 25 pages Disclosure of Agency Relationship
12/34/56
EX-10.11
from 8-K 24 pages Disclosure of Agency Relationship
12/34/56
EX-10.11
from 425 24 pages Disclosure of Agency Relationship
12/34/56
EX-10.10
from 8-K 25 pages Disclosure of Agency Relationship
12/34/56